Triggering of cardiac events by sexual activity: findings from a case-crossover analysis. Am J Cardiol. 2000;86:14F 8F. 485. Ebrahim S, May M, Ben Shlomo Y, et al. Sexual intercourse and risk of ischaemic stroke and coronary heart disease: the Caerphilly study. J Epidemiol Community Health. 2002;56:99 102. 486. Dahabreh IJ, Paulus JK. Association of episodic physical and sexual activity with triggering of acute cardiac events: systematic review and meta-analysis. JAMA. 2011;305:1225 33. 487. Cheitlin MD. Sexual activity and cardiac risk. Am J Cardiol. 2005;96: 24M 8M. 488. Grimm RH Jr, Grandits GA, Prineas RJ, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hyper- tension Study (TOMHS). Hypertension. 1997;29:8 14. 489. Dusing R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs. 2005;65:773 86. 490. Franzen D, Metha A, Seifert N, et al. Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, ran- domized and double blinded study. Int J Impot Res. 2001;13:348 51. 491. Baumhakel M, Schlimmer N, Kratz M, et al. Cardiovascular risk, drugs and erectile function a systematic analysis. Int J Clin Pract. 2011;65: 289 98. 492. Ko DT, Hebert PR, Coffey CS, et al. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA. 2002;288:351 7. 493. Padma-nathan H, Eardley I, Kloner RA, et al. A 4-year update on the safety of sildenafil citrate (Viagra). Urology. 2002;60:67 90. 494. Montorsi F, Verheyden B, Meuleman E, et al. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol. 2004;45:339 44. 495. Kloner RA, Jackson G, Emmick JT, et al. Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, dox- azosin and tamsulosin in healthy normotensive men. J Urol. 